Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas

BACKGROUND: The prognostic potential of PD-L1 is currently unclear in gastric carcinomas, although the immune checkpoint PD-1/PD-L1 inhibitors have produced promising results in clinical trials. METHODS: We explored the prognostic implications of programmed death ligand 1 (PD-L1) in 514 consecutive...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Euno, Chang, Mee Soo, Byeon, Sun-ju, Jin, Heejin, Jung, Kyeong Cheon, Kim, Haeryoung, Lee, Kook Lae, Kim, Won, Park, Jin Hyun, Kim, Ki Hwan, Kim, Jin-Soo, Choi, In Sil, Han, Dong-Seok, Ahn, Hye Seong, Heo, Seung Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271517/
https://www.ncbi.nlm.nih.gov/pubmed/32498695
http://dx.doi.org/10.1186/s13000-020-00979-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271517/
https://www.ncbi.nlm.nih.gov/pubmed/32498695
http://dx.doi.org/10.1186/s13000-020-00979-z

Ejemplares similares